Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure. [electronic resource]
Producer: 20180105Description: 268-277 p. digitalISSN:- 2213-1787
- Aged
- Cardiovascular Diseases -- mortality
- Cause of Death
- Chronic Disease
- Cohort Studies
- Female
- Heart Failure -- blood
- Humans
- Male
- Middle Aged
- Mortality
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Receptors, Urokinase Plasminogen Activator -- blood
- Reproducibility of Results
- Risk Assessment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.